We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

AI Tool Accurately Predicts Cancer Three Years Prior to Diagnosis

By HospiMedica International staff writers
Posted on 24 Aug 2023
Print article
Image: AI can predict certain forms of esophageal and stomach cancer (Photo courtesy of Freepik)
Image: AI can predict certain forms of esophageal and stomach cancer (Photo courtesy of Freepik)

Over the past five decades, there has been a surge in cases of a specific type of esophageal and stomach cancer - esophageal adenocarcinoma (EAC) and gastric cardia adenocarcinoma (GCA). Both cancers have high fatality rates, although preventive measures can make a difference. Screenings can detect pre-cancerous changes, such as Barrett’s esophagus, often identified in individuals with long-standing gastroesophageal reflux disease (GERD). Although guidelines suggest screening for high-risk patients, many healthcare providers remain unfamiliar with this recommendation. Now, a new artificial intelligence (AI) tool offers accurate predictions for these forms of esophageal and stomach cancer at least three years in advance of a diagnosis.

Researchers at Michigan Medicine (Ann Arbor, MI, USA) have developed an automated tool integrated into the electronic health record (EHR). This tool has the potential to bridge the awareness gap between healthcare providers and patients with an elevated risk of developing EAC and GCA. The researchers employed a specific type of AI for analyzing data related to EAC and GCA rates across more than 10 million U.S. veterans in order to develop and validate the Kettles Esophageal and Cardia Adenocarcinoma prediction tool, or K-ECAN for short.

K-ECAN leverages readily accessible data from the EHR, including patient demographics, weight, prior diagnoses, and routine lab results, to gauge an individual's risk of developing EAC and GCA. Outperforming published guidelines and previously validated prediction tools, K-ECAN accurately predicts cancer at least three years ahead of a diagnosis. Integrating this AI tool into the EHR could automatically notify healthcare providers about patients at a higher risk of developing EAC and GCA.

“Symptoms of GERD, like heartburn, are an important risk factor for esophageal adenocarcinoma,” said Joel Rubenstein, M.D., M.S., professor of internal medicine at Michigan Medicine. “But most people with GERD symptoms will never develop esophageal adenocarcinoma and gastric cardia adenocarcinoma. In addition, roughly half of the patients with this form of cancer never experienced prior GERD symptoms at all. This makes K-ECAN particularly useful because it can identify people who are at elevated risk, regardless of whether they have GERD symptoms or not.”

Related Links:
Michigan Medicine 

Gold Member
12-Channel ECG
Gold Member
Solid State Kv/Dose Multi-Sensor
Silver Member
Wireless Mobile ECG Recorder
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80

Print article


Critical Care

view channel
Image: The new WHO guidelines include 14 good practice statements and 23 recommendations on key areas for health workers (Photo courtesy of Shutterstock)

WHO Publishes First Global Guidelines to Reduce Bloodstream Infections from Catheter Use

Up to 70% of all inpatients require a catheter, specifically a peripherally inserted catheter (PIVC), at some point during their hospital stay. Patients who receive treatments via catheters are particularly... Read more

Surgical Techniques

view channel
Image: The researchers tweaked borophene to interact with cells and other biological units in unique ways (Photo courtesy of Dipanjan Pan/Penn State)

New Two-Dimensional Material Paves Way for Safer, More Effective Implantable Medical Devices

Borophene, first synthesized in 2015, is an atomically thin version of boron that surpasses graphene—the two-dimensional (2D) version of carbon—in conductivity, thinness, lightness, strength, and flexibility.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.